Globus Medical, Inc.

GMED Healthcare Medical Devices

Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024. In the quarter to June 2026, revenue grew 5.94%, EPS fell 25.3% and free cash flow grew 571.3%, each against the same quarter a year earlier. Revenue growth for ten consecutive years, operating cash flow growth for three.

76.71 2.13 −2.70%
Market cap
$10.6B
P/E
19.3×
Fwd P/E
20.3×
Dividend yield
—
F-score
9/9
Altman Z
11.30
Beneish M
−2.31
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
19.90 19.81 21.94 18.36

+8 more quarters

P/S ratio
3.39 3.76 4.02 2.78
P/FCF ratio
14.50 19.75 20.75 13.76
P/Operating CF
50.88 57.63 47.49 30.85
P/B ratio
2.24 2.46 2.58 1.75
EV/Sales
3.48 3.84 4.12 2.95
EV/EBITDA
11.72 14.27 15.47 11.36
EV/FCF
14.86 20.14 21.28 14.60
Current Ratio
4.62 4.56 4.26 4.13
Net Debt/EBITDA
(2.36) (2.86) (2.27) (1.81)
Debt/Equity
0.00 0.00 0.00 0.00
Earnings Yield
5.02% 5.05% 4.56% 5.45%
Free Cash Flow Yield
6.90% 5.06% 4.82% 7.27%
Free Cash Flow per Share
1.31 1.20 1.50 1.52
Book value per Share
35.31 34.96 33.82 32.70
Free Cash Flow
176.57 162.75 202.31 204.21
EV/EBIT
17.10 22.31 25.24 22.04
Other line items

Show all line items

Columns are period end dates